121 related articles for article (PubMed ID: 8528059)
1. The retinoblastoma gene (RB-1) status in multiple myeloma: a report on 35 cases.
Zandecki M; Facon T; Preudhomme C; Vanrumbeke M; Vachee A; Quesnel B; Lai JL; Cosson A; Fenaux P
Leuk Lymphoma; 1995 Aug; 18(5-6):497-503. PubMed ID: 8528059
[TBL] [Abstract][Full Text] [Related]
2. Deletion of the retinoblastoma gene in multiple myeloma.
Dao DD; Sawyer JR; Epstein J; Hoover RG; Barlogie B; Tricot G
Leukemia; 1994 Aug; 8(8):1280-4. PubMed ID: 8057662
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of the retinoblastoma gene appears to be very uncommon in myelodysplastic syndromes.
Preudhomme C; Vachee A; Lepelley P; Vanrumbeke M; Zandecki M; Quesnel B; Cosson A; Fenaux P
Br J Haematol; 1994 May; 87(1):61-7. PubMed ID: 7524620
[TBL] [Abstract][Full Text] [Related]
4. The retinoblastoma susceptibility gene RB-1 in multiple myeloma.
Juge-Morineau N; Harousseau JL; Amiot M; Bataille R
Leuk Lymphoma; 1997 Jan; 24(3-4):229-37. PubMed ID: 9156653
[TBL] [Abstract][Full Text] [Related]
5. Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma.
Zhang X; Xu HJ; Murakami Y; Sachse R; Yashima K; Hirohashi S; Hu SX; Benedict WF; Sekiya T
Cancer Res; 1994 Aug; 54(15):4177-82. PubMed ID: 8033150
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of retinoblastoma gene inactivation in the spectrum of neuroendocrine lung tumors.
Gouyer V; Gazzéri S; Bolon I; Drevet C; Brambilla C; Brambilla E
Am J Respir Cell Mol Biol; 1998 Feb; 18(2):188-96. PubMed ID: 9476905
[TBL] [Abstract][Full Text] [Related]
7. Retinoblastoma gene mutations in primary human prostate cancer.
Kubota Y; Fujinami K; Uemura H; Dobashi Y; Miyamoto H; Iwasaki Y; Kitamura H; Shuin T
Prostate; 1995 Dec; 27(6):314-20. PubMed ID: 7501543
[TBL] [Abstract][Full Text] [Related]
8. RB1 germ-line deletions in Argentine retinoblastoma patients.
Fernández C; Repetto K; Dalamon V; Bergonzi F; Ferreiro V; Szijan I
Mol Diagn Ther; 2007; 11(1):55-61. PubMed ID: 17286450
[TBL] [Abstract][Full Text] [Related]
9. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA
Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583
[TBL] [Abstract][Full Text] [Related]
10. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB.
Pei L; Melmed S; Scheithauer B; Kovacs K; Benedict WF; Prager D
Cancer Res; 1995 Apr; 55(8):1613-6. PubMed ID: 7712461
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel mutations in the RB1 gene in Mexican patients with retinoblastoma.
Rodríguez M; Salcedo M; González M; Coral-Vazquez R; Salamanca F; Arenas D
Cancer Genet Cytogenet; 2002 Oct; 138(1):27-31. PubMed ID: 12419581
[TBL] [Abstract][Full Text] [Related]
12. Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma.
Krämer A; Schultheis B; Bergmann J; Willer A; Hegenbart U; Ho AD; Goldschmidt H; Hehlmann R
Leukemia; 2002 Sep; 16(9):1844-51. PubMed ID: 12200702
[TBL] [Abstract][Full Text] [Related]
13. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
14. The retinoblastoma gene is involved in malignant progression of astrocytomas.
Henson JW; Schnitker BL; Correa KM; von Deimling A; Fassbender F; Xu HJ; Benedict WF; Yandell DW; Louis DN
Ann Neurol; 1994 Nov; 36(5):714-21. PubMed ID: 7979217
[TBL] [Abstract][Full Text] [Related]
15. Loss of retinoblastoma gene function and heterozygosity at the RB locus in renal cortical neoplasms.
Lai S; Benedict WF; Silver SA; El-Naggar AK
Hum Pathol; 1997 Jun; 28(6):693-7. PubMed ID: 9191003
[TBL] [Abstract][Full Text] [Related]
16. Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells.
Gutiérrez NC; Hernández JM; García JL; Almeida J; Mateo G; González MI; Hernández J; Fernández-Calvo J; San Miguel JF
Haematologica; 2000 Nov; 85(11):1146-52. PubMed ID: 11064466
[TBL] [Abstract][Full Text] [Related]
17. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ
Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510
[TBL] [Abstract][Full Text] [Related]
18. Reduced transcription of the RB2/p130 gene in human lung cancer.
Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group.
Reissmann PT; Koga H; Takahashi R; Figlin RA; Holmes EC; Piantadosi S; Cordon-Cardo C; Slamon DJ
Oncogene; 1993 Jul; 8(7):1913-9. PubMed ID: 8390038
[TBL] [Abstract][Full Text] [Related]
20. Abundance and state of phosphorylation of the retinoblastoma gene product in human pituitary tumors.
Woloschak M; Yu A; Xiao J; Post KD
Int J Cancer; 1996 Jul; 67(1):16-9. PubMed ID: 8690518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
